While initial researches documented that Rheumatoid Arthritis (RA) patients who took biologic agents had decreased symptoms with those receiving traditional treatment, safety of the drugs remains a concern. The Authors in this paper review the safety of the RA new therapeutic approach utilizing biological agents and compare it with the safety of conventional disease-modifying anti-rheumatic drugs (DMARDs).
Safety of conventional drugs and biologic agents for Rheumatoid Arthritis / Amoroso, Antonio; Gigante, Antonietta; C., Gianni; D., Amoroso; D., Zennaro; S., Galluzzo; Caccavo, Domenico. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - STAMPA. - 7:5(2003), pp. 139-145.
Safety of conventional drugs and biologic agents for Rheumatoid Arthritis
AMOROSO, Antonio;GIGANTE, ANTONIETTA;
2003
Abstract
While initial researches documented that Rheumatoid Arthritis (RA) patients who took biologic agents had decreased symptoms with those receiving traditional treatment, safety of the drugs remains a concern. The Authors in this paper review the safety of the RA new therapeutic approach utilizing biological agents and compare it with the safety of conventional disease-modifying anti-rheumatic drugs (DMARDs).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
